These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32653901)

  • 1. Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls.
    Bultink IEM; de Vries F; van Vollenhoven RF; Lalmohamed A
    Rheumatology (Oxford); 2021 Jan; 60(1):207-216. PubMed ID: 32653901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
    Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
    J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom.
    Bultink IE; Harvey NC; Lalmohamed A; Cooper C; Lems WF; van Staa TP; de Vries F
    Osteoporos Int; 2014 Apr; 25(4):1275-83. PubMed ID: 24297094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.
    Rees F; Doherty M; Grainge MJ; Lanyon P; Davenport G; Zhang W
    Rheumatology (Oxford); 2016 May; 55(5):854-60. PubMed ID: 26748350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
    Lorenzo-Vizcaya A; Isenberg D
    Lupus; 2021 Apr; 30(5):702-706. PubMed ID: 33472522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause and cause-specific mortality in patients with Behçet disease versus the general population.
    Choi SR; Shin A; Ha YJ; Lee YJ; Lee EB; Lee ES; Kang EH
    Br J Dermatol; 2024 May; 190(6):858-866. PubMed ID: 38320213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
    Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study.
    Huang YF; Chang YS; Chen WS; Tsao YP; Wang WH; Liao HT; Tsai CY; Lai CC
    Lupus; 2019 Jan; 28(1):19-26. PubMed ID: 30458691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Fracture Risks Among United States Medicaid Enrollees With and Those Without Systemic Lupus Erythematosus.
    Tedeschi SK; Kim SC; Guan H; Grossman JM; Costenbader KH
    Arthritis Rheumatol; 2019 Jul; 71(7):1141-1146. PubMed ID: 30714690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for mortality in systemic lupus erythematosus patients: Analysis of adult and pediatric cohorts in Taiwan.
    Lai CC; Sun YS; Chen WS; Liao HT; Chen MH; Tsai CY; Huang DF; Chou CT; Chang DM
    J Chin Med Assoc; 2022 Nov; 85(11):1044-1050. PubMed ID: 36343272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study.
    Lao C; White D; Rabindranath K; Van Dantzig P; Foxall D; Lawrenson R
    Rheumatology (Oxford); 2024 May; 63(6):1560-1567. PubMed ID: 37632770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good survival rates in systemic lupus erythematosus in southern Sweden, while the mortality rate remains increased compared with the population.
    Ingvarsson RF; Landgren AJ; Bengtsson AA; Jönsen A
    Lupus; 2019 Oct; 28(12):1488-1494. PubMed ID: 31551031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.
    Wu XY; Yang M; Xie YS; Xiao WG; Lin J; Zhou B; Guan X; Luo CN; Che N; Liu XZ; Wang C; Teng JL; Cheng XB; Ye JN; Su YT; Shi H; Yin YF; Liu MR; Sun Y; Hu QY; Zhou ZC; Chi HH; Liu Y; Zhang X; Chen JW; Zhang MJ; Zhao DB; Yang CD; Wu LJ; Liu HL
    Clin Rheumatol; 2019 Jan; 38(1):107-115. PubMed ID: 30123930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013.
    Falasinnu T; Rossides M; Chaichian Y; Simard JF
    Public Health Rep; 2018; 133(4):481-488. PubMed ID: 29928843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox.
    Gómez-Puerta JA; Barbhaiya M; Guan H; Feldman CH; Alarcón GS; Costenbader KH
    Arthritis Rheumatol; 2015 Mar; 67(3):752-60. PubMed ID: 25590668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.
    Sule S; Fivush B; Neu A; Furth S
    Pediatr Nephrol; 2011 Jan; 26(1):93-8. PubMed ID: 20890767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.